Diversity, Equity, and Inclusion in Oncology (2026)
-
Register
- Non-member - $40
- Member - Free!
The Diversity, Equity, and Inclusion in Oncology modules by APSHO include 8 comprehensive and self-paced modules to equip you with the understanding of health disparities, inequities and structural racism in the hematology/oncology setting and how these affect patient outcomes. (Additionally, one of the modules addresses health disparities and inequities in substance use disorders and this module meets the DEA requirement for training on substance use disorder.) 3.5 CE-Accredited Hours
-
Contains 5 Component(s), Includes Credits
0.75 CE-Accredited Hours
- Define substance use disorder (SUD) and describe health disparities related to this
- List factors contributing to health disparities in SUD
- Discuss the role of the advanced practitioner in addressing health disparities in the patient with SUD
-
Contains 5 Component(s), Includes Credits
0.25 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Define racism and summarize its impact on patient care.
- List different types of historical structural racism.
- State the role of the AP in dismantling structural racism.
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Differentiate between health disparity versus health inequity
- Discuss how race, ethnicity, and socioeconomic status contribute to breast cancer disparities
- Describe the impact of culture, implicit bias, and institutional racism on treatment outcomes and mortality
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Define health disparity and health inequity and describe contributing factors to these issues
- Define and illustrate social determinants of health
- List examples of health disparities in oncology/hematology
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours
- Articulate the impact of lung cancer health disparity in various populations
- Identify the disparities in lung cancer in screening, diagnosis, and treatment
- Describe the advanced practitioner role in lung cancer screening and the impact on racial and ethnic survival disparities
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Articulate the impact of colorectal cancer (CRC) in Black individuals in terms of mortality
- Identify the disparities in CRC in screening, diagnosis, and treatment
- Describe the advanced practitioner role in screening and the impact on racial and ethnic survival disparities
-
Contains 5 Component(s)
Non-CE-accredited module
- Describe disparities in prostate cancer prevalence and outcomes
- Identify the social determinants related to prostate cancer outcomes
- Assess barriers to screening and treatment in local communities
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours
- Describe the importance of including diverse populations in clinical trials
- Identify strategies to improve diversity, inclusion, and equity in clinical trials
- List barriers or perceptions that prevent or limit diversity, inclusion, and equity in clinical trials
